When a woman's water breaks before labor starts, the risk of infection rises. This risk grows significantly if the water has been broken for eighteen hours or more. A study looked at how to handle this specific situation for women with a single baby due. The researchers compared giving ampicillin alone versus adding gentamicin to the treatment plan. They found that the combined approach worked better at preventing serious infections for the mother. The group receiving both drugs had much lower rates of chorioamnionitis and endometritis compared to those getting ampicillin by itself. They also saw fewer cases of postpartum infections and shorter hospital stays for those mothers. The data showed that adding gentamicin reduced the chance of needing neonatal intensive care for the newborn. This trial took place in a large university hospital and included two hundred and seven women. The results suggest a clear benefit for this specific group of patients. The study did not report any safety concerns or side effects from the extra medication. While the sample size was modest, the findings point toward a practical change in how doctors might treat these patients.
Ampicillin-gentamicin cuts chorioamnionitis risk to 1.9% vs 10.6% with ampicillin alone in PROMAdding gentamicin to ampicillin cuts infection rates for women with long-term water breaks
AI-generated summary of the cited source, checked by automated accuracy review. How we work
This randomized controlled trial enrolled 207 women with singleton term pregnancies, prelabor rupture of membranes for at least 18 hours, and negative group B Streptococcus colonization at a tertiary university-affiliated hospital. The intervention was intravenous ampicillin (2 g every 6 hours) plus gentamicin (5 mg/kg every 24 hours); the comparator was intravenous ampicillin (2 g every 6 hours) alone. The primary outcome was the incidence of clinical chorioamnionitis and endometritis.
The combination regimen significantly reduced clinical chorioamnionitis (1.9% vs 10.6%; P=.019; 95% confidence interval, 7-45). Endometritis rates were similar between groups. Postpartum infectious morbidity was lower with combination therapy (1.9% vs 9.6%; P=.033), as was postpartum hospitalization of 5 days or longer (3.9% vs 13.5%; P=.024).
Neonatal intensive care unit admission for suspected early-onset sepsis was lower (2.9% vs 8.7%; P=.031). Positive chorioamniotic cultures were less frequent (20.9% vs 36.7%; P=.029), and prevalence of Enterobacteriaceae species was lower (12.1% vs 25.6%; P=.033).
Safety data, including adverse events and discontinuations, were not reported. The study was conducted at a single center, and follow-up duration was not reported. These findings suggest a potential benefit of combination antibiotic therapy for prolonged PROM, but practice decisions should consider the limited safety information and need for external validation.